Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo MASI2.83%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted resolutions to terminate the employment of Masimo’s ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe two of its design patents as part of a broader intellectual property ...

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might ... of modern pulse oximeters,” and its tech ...

Masimo has obtained an import ban for an Apple Watch feature in the USA. Apple sued back and won a Pyrrhic victory. A new chapter has been added to the conflict between Apple and medical ...

A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.